Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
British Journal of Cancer|June 26, 2008
Primary resistance to cetuximab therapy in EGFR FISH-positive colorectal cancer patientsF Cappuzzo, M Varella-Garcia, G Finocchiaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 8, 2006
Insulin-like growth factor receptor 1 (IGFR-1) is significantly associated with longer survival in non-small-cell lung cancer patients treated with gefitinibF Cappuzzo, L Toschi, G Tallini, et al.
British Journal of Cancer|October 29, 2014
PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patientsA D'Incecco, M Andreozzi, V Ludovini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2015
Lung cancer patients with HER2 mutations treated with chemotherapy and HER2-targeted drugs: results from the European EUHER2 cohortJ Mazières, F Barlesi, T Filleron, et al.
British Journal of Cancer|August 2, 2012
Increased MET and HGF gene copy numbers are associated with trastuzumab failure in HER2-positive metastatic breast cancerG Minuti, F Cappuzzo, R Duchnowska, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 17, 2018
Correlation of extent of ALK FISH positivity and crizotinib efficacy in three prospective studies of ALK-positive patients with non-small-cell lung cancerJ-C Soria, S N Ho, M Varella-Garcia, et al.
Molecular Cancer|November 13, 2024
The PI3K-AKT-mTOR axis persists as a therapeutic dependency in KRASG12D-driven non-small cell lung cancerW J McDaid, L Wilson, H Adderley, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 17, 2024
Patient Experiences of Using Wearable Health Monitors During Cancer Treatment: A Qualitative StudyS Collinson, S Ingram-Walpole, C Jackson, et al.
Pageof 9